Literature DB >> 26185405

Vasopressor and Inotropic Management Of Patients With Septic Shock.

Sacha Pollard, Stephanie B Edwin, Cesar Alaniz.   

Abstract

Numerous studies have evaluated the role of vasopressors and inotropes in the management of septic shock. This review assesses available evidence for the use of specific vasopressors in the management of septic shock. Use of adjunctive vasopressor therapy is also evaluated, examining the potential value of individual agents. Lastly, inotropic agents are evaluated for use in patients with myocardial dysfunction.

Entities:  

Year:  2015        PMID： 26185405      PMCID： PMC4495871     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  63 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  HEMODYNAMIC EFFECTS OF PRESSOR AGENTS IN SEPTIC AND MYOCARDIAL INFARCTION SHOCK.

Authors:  H SMULYAN; R P CUDDY; R H EICH
Journal:  JAMA       Date:  1964-10-19       Impact factor: 56.272

3.  Nor-epinephrine; effect in normal subjects; use in treatment of shock unresponsive to other measures.

Authors:  J H MOYER; J M SKELTON; L C MILLS
Journal:  Am J Med       Date:  1953-09       Impact factor: 4.965

4.  Comparison of dopamine and norepinephrine in the treatment of shock.

Authors:  Daniel De Backer; Patrick Biston; Jacques Devriendt; Christian Madl; Didier Chochrad; Cesar Aldecoa; Alexandre Brasseur; Pierre Defrance; Philippe Gottignies; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

5.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 6.  Vasopressors for shock.

Authors:  M Müllner; B Urbanek; C Havel; H Losert; F Waechter; G Gamper
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

Authors:  Djillali Annane; Philippe Vignon; Alain Renault; Pierre-Edouard Bollaert; Claire Charpentier; Claude Martin; Gilles Troché; Jean-Damien Ricard; Gérard Nitenberg; Laurent Papazian; Elie Azoulay; Eric Bellissant
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

8.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

9.  Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock.

Authors:  Khaled M Mahmoud; Amany S Ammar
Journal:  Indian J Crit Care Med       Date:  2012-04

10.  One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response.

Authors:  Petch Wacharasint; John H Boyd; James A Russell; Keith R Walley
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097
View more
  4 in total

1.  cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis.

Authors:  Ruochan Chen; Ling Zeng; Shan Zhu; Jiao Liu; Herbert J Zeh; Guido Kroemer; Haichao Wang; Timothy R Billiar; Jianxin Jiang; Daolin Tang; Rui Kang
Journal:  Sci Adv       Date:  2019-05-22       Impact factor: 14.136

Review 2.  Serum leptin level as a diagnostic and prognostic marker in infectious diseases and sepsis: A comprehensive literature review.

Authors:  Victoria Birlutiu; Loredana Camelia Boicean
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

3.  Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb®) in patients with sepsis and septic shock.

Authors:  Rajib Paul; Prachee Sathe; Senthil Kumar; Shiva Prasad; Ma Aleem; Prashant Sakhalvalkar
Journal:  World J Crit Care Med       Date:  2021-01-09

Review 4.  Adrenergic regulation of immune cell function and inflammation.

Authors:  Drashya Sharma; J David Farrar
Journal:  Semin Immunopathol       Date:  2020-11-20       Impact factor: 9.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.